- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 5/0789 - Stem cells; Multipotent progenitor cells
Patent holdings for IPC class C12N 5/0789
Total number of patents in this class: 1864
10-year publication summary
85
|
118
|
121
|
184
|
170
|
174
|
144
|
164
|
145
|
50
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Children's Medical Center Corporation | 1780 |
57 |
The Regents of the University of California | 18943 |
36 |
Wisconsin Alumni Research Foundation | 3774 |
36 |
FATE Therapeutics, Inc. | 176 |
30 |
President and Fellows of Harvard College | 5792 |
26 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
24 |
Vor Biopharma, Inc. | 79 |
24 |
Ospedale San Raffaele S.r.l. | 240 |
23 |
The General Hospital Corporation | 4517 |
21 |
Factor Bioscience Inc. | 96 |
21 |
The Trustees of Columbia University in the City of New York | 3440 |
18 |
FUJIFILM Cellular Dynamics, Inc. | 131 |
18 |
Astellas Institute for Regenerative Medicine | 118 |
17 |
Fondazione Telethon | 152 |
17 |
Fred Hutchinson Cancer Research Center | 372 |
17 |
Fred Hutchinson Cancer Center | 376 |
15 |
The University of Tokyo | 3903 |
14 |
Adaptimmune Limited | 179 |
13 |
Children's Hospital Medical Center | 690 |
13 |
Universite de Montreal | 341 |
13 |
Other owners | 1411 |